ketamine has been researched along with Albers-Schoenberg Disease in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soberón, JR | 1 |
| Arzillo, S | 1 |
| Myers, SL | 1 |
| King, JJ | 1 |
1 other study available for ketamine and Albers-Schoenberg Disease
| Article | Year |
|---|---|
Osteopetrosis-Anesthetic Considerations for Total Knee Arthroplasty: A Case Report.
Topics: Administration, Intravenous; Anesthetics; Arthroplasty, Replacement, Knee; Dexamethasone; Humans; Ke | 2019 |